We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 3 for:    Interleukin-2 in Metastatic Melanoma quan

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

This study has been withdrawn prior to enrollment.
(No participants enrolled)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01833767
First Posted: April 17, 2013
Last Update Posted: August 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jordan Waypa, Western Regional Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)